CE FINANCIAL STATEMENTS

Celanese Corporation — balance sheet, income statement and cash flow trends

CECelanese Corporation

🇺🇸 USA · NYSE · Basic Materials · Chemicals

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue9.5 B $-5.6%

Gross Profit1.9 B $-17.4%

Operating Income-725 M $—

EBITDA407 M $+32.1%

Net Income-1.1 B $—

Peer Comparison· Chemicals

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
CE	-5.6%	19.8%	4.3%	-11.5%
MX	-0.8%	15.2%	22.3%	-1.3%
RDX	8.3%	21.5%	11.4%	6.3%
PETKM	2.4%	-2.1%	-7.1%	-7.5%
BAS	-4.8%	24.3%	12.0%	2.9%
Industry median	-2.4%	8.5%	6.1%	-3.8%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
CE	-5.6%	19.8%	4.3%	-11.5%
OLN	2.6%	6.4%	7.4%	-1.9%
HUN	-4.7%	12.9%	2.2%	-5.7%
REX	2.6%	16.5%	18.1%	14.1%
DOW	-7.7%	6.2%	2.1%	-7.0%
GPRE	-21.0%	5.8%	7.4%	-0.8%
Industry median	-2.4%	8.5%	6.1%	-3.8%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity4.1 B $19%
Current Liabilities4.3 B $20%
Long-term Liabilities12.9 B $61%

Key Figures

YoY change

Total Assets21.7 B $-6.3%

Total Liabilities17.3 B $-1.9%

Total Equity4.1 B $-21.7%

Cash & ST Investments1.8 B $+84.9%

Total Debt12.6 B $-4.5%

Net Debt10.8 B $-10.9%

Peer Comparison· Chemicals

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
CE	1.38	309.0%	26.53	18.7%
MX	1.96	143.4%	3.76	33.4%
RDX	3.99	12.6%	-0.52	74.1%
PETKM	0.56	76.7%	-6.76	41.2%
BAS	1.91	69.0%	2.84	41.9%
Industry median	1.88	73.9%	3.30	41.6%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
CE	1.38	309.0%	26.53	18.7%
OLN	1.36	190.9%	6.30	23.6%
HUN	1.18	92.8%	17.08	37.6%
REX	6.76	3.1%	-2.90	77.9%
DOW	1.85	128.7%	18.48	25.5%
GPRE	1.71	71.2%	2.62	49.5%
Industry median	1.88	73.9%	3.30	41.6%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow1.2 B $+31.4%

Capital Expenditures307 M $-23.3%

Free Cash Flow878 M $+74.9%

Dividends Paid-13 M $-105.6%

Peer Comparison· Chemicals

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
CE	12.5%	9.2%	3.2%	-108.2%
MX	18.2%	16.2%	2.0%	-1,449.4%
RDX	7.6%	7.2%	0.4%	121.6%
PETKM	3.3%	6.3%	4.7%	-43.8%
BAS	9.6%	2.9%	6.7%	333.4%
Industry median	6.7%	3.7%	4.0%	-24.4%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
CE	12.5%	9.2%	3.2%	-108.2%
OLN	7.6%	4.5%	3.1%	-402.8%
HUN	5.4%	2.4%	3.1%	-95.7%
REX	18.2%	7.0%	11.2%	128.6%
DOW	7.2%	-3.5%	10.7%	-101.9%
GPRE	6.0%	4.6%	1.4%	-759.3%
Industry median	6.7%	3.7%	4.0%	-24.4%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.